Okami Medical, based in Aliso Viejo, California and founded in 2017 by the Inari team through the Inceptus Medical incubator, is a commercial-stage company focused on innovative solutions for peripheral vascular embolization across a wide range of conditions.

The company’s flagship LOBO occluder features a multi-disc, braided nitinol design with high-density, small-pore technology, enabling rapid, reliable, and durable vessel closure. Delivered via catheter, the device allows for precise placement and minimizes migration risk, making it ideal for complex anatomies such as vascular malformations, aneurysms, and hypervascular tumors.

In 2025, Gilde invested in Okami Medical to support its commercial expansion, clinical evidence generation, and indication growth, aiming to accelerate adoption and drive significant revenue growth in the peripheral vascular market.